Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Devine

Showing results (451-460 of 577) with videos related to

Pageof 58
Sort By:
Journal of Molecular Recognition : JMR|January 26, 2016
Solution NMR characterization of apical membrane antigen 1 and small molecule interactions as a basis for designing new antimalarialsBankala Krishnarjuna, San Sui Lim, Shane M Devine, et al.
Blood Advances|April 30, 2024
Long-term outcomes of peripheral blood stem cell unrelated donors mobilized with filgrastimHeather E Stefanski, Michelle Kuxhausen, Stephanie Bo-Subait, et al.
Leukemia|September 27, 2013
CS1-specific chimeric antigen receptor (CAR)-engineered natural killer cells enhance in vitro and in vivo antitumor activity against human multiple myelomaJ Chu, Y Deng, D M Benson, et al.
Blood|May 6, 2017
Phase 1 multicenter trial of brentuximab vedotin for steroid-refractory acute graft-versus-host diseaseYi-Bin Chen, Miguel-Angel Perales, Shuli Li, et al.
Experimental Hematology|February 13, 2001
Mesenchymal stem cells are capable of homing to the bone marrow of non-human primates following systemic infusionS M Devine, A M Bartholomew, N Mahmud, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1996
Minimal toxicity and mortality in high-risk breast cancer patients receiving high-dose cyclophosphamide, thiotepa, and carboplatin plus autologous marrow/stem-cell transplantation and comprehensive supportive careH K Holland, S P Dix, R B Geller, et al.
Microbiology (Reading, England)|February 13, 2010
pBaSysBioII: an integrative plasmid generating gfp transcriptional fusions for high-throughput analysis of gene expression in Bacillus subtilisEric Botella, Mark Fogg, Matthieu Jules, et al.
Journal of Hematology & Oncology|June 14, 2017
Rituximab-containing reduced-intensity conditioning improves progression-free survival following allogeneic transplantation in B cell non-Hodgkin lymphomaNarendranath Epperla, Kwang Woo Ahn, Sairah Ahmed, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 31, 2011
Characteristics of CliniMACS® System CD34-enriched T cell-depleted grafts in a multicenter trial for acute myeloid leukemia-Blood and Marrow Transplant Clinical Trials Network (BMT CTN) protocol 0303Carolyn A Keever-Taylor, Steven M Devine, Robert J Soiffer, et al.
Science Advances|February 1, 2021
Spin-orbit coupling suppression and singlet-state blocking of spin-triplet Cooper pairsSachio Komori, James M Devine-Stoneman, Kohei Ohnishi, et al.
Pageof 58

Showing results (451-460 of 577) with videos related to

Sort By:
Pageof 58
Journal of Molecular Recognition : JMR|January 26, 2016
Solution NMR characterization of apical membrane antigen 1 and small molecule interactions as a basis for designing new antimalarialsBankala Krishnarjuna, San Sui Lim, Shane M Devine, et al.
Blood Advances|April 30, 2024
Long-term outcomes of peripheral blood stem cell unrelated donors mobilized with filgrastimHeather E Stefanski, Michelle Kuxhausen, Stephanie Bo-Subait, et al.
Leukemia|September 27, 2013
CS1-specific chimeric antigen receptor (CAR)-engineered natural killer cells enhance in vitro and in vivo antitumor activity against human multiple myelomaJ Chu, Y Deng, D M Benson, et al.
Blood|May 6, 2017
Phase 1 multicenter trial of brentuximab vedotin for steroid-refractory acute graft-versus-host diseaseYi-Bin Chen, Miguel-Angel Perales, Shuli Li, et al.
Experimental Hematology|February 13, 2001
Mesenchymal stem cells are capable of homing to the bone marrow of non-human primates following systemic infusionS M Devine, A M Bartholomew, N Mahmud, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1996
Minimal toxicity and mortality in high-risk breast cancer patients receiving high-dose cyclophosphamide, thiotepa, and carboplatin plus autologous marrow/stem-cell transplantation and comprehensive supportive careH K Holland, S P Dix, R B Geller, et al.
Microbiology (Reading, England)|February 13, 2010
pBaSysBioII: an integrative plasmid generating gfp transcriptional fusions for high-throughput analysis of gene expression in Bacillus subtilisEric Botella, Mark Fogg, Matthieu Jules, et al.
Journal of Hematology & Oncology|June 14, 2017
Rituximab-containing reduced-intensity conditioning improves progression-free survival following allogeneic transplantation in B cell non-Hodgkin lymphomaNarendranath Epperla, Kwang Woo Ahn, Sairah Ahmed, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 31, 2011
Characteristics of CliniMACS® System CD34-enriched T cell-depleted grafts in a multicenter trial for acute myeloid leukemia-Blood and Marrow Transplant Clinical Trials Network (BMT CTN) protocol 0303Carolyn A Keever-Taylor, Steven M Devine, Robert J Soiffer, et al.
Science Advances|February 1, 2021
Spin-orbit coupling suppression and singlet-state blocking of spin-triplet Cooper pairsSachio Komori, James M Devine-Stoneman, Kohei Ohnishi, et al.
Pageof 58